NCT00614991View on ClinicalTrials.gov

An Interaction Study to Assess Drug Levels in Healthy Adult Subjects

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Healthy
Interventions
DRUG

Raltegravir

400mg BID

DRUG

Fosamprenavir

1400mg BID, 700 mg BID or 1400 mg QD

DRUG

Ritonavir

100 mg BID or QD

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Garden State Infectious Disease Associates, PA

OTHER